FIELD: chemistry.
SUBSTANCE: present invention relates to compounds of formula I and their pharmaceutically acceptable salts which have inhibitory properties towards mGluR5. In formula I , P represents phenyl; R1 is bonded to P through a carbon atom on ring P and is selected from a group consisting of halogen, C1-6alkylhalogen, OC1-6alkylhalogen, C1-6alkyl, OC1-6alkyl and C0-6alkylcyano; X1 is selected from a group consisting of N, NR4 and CR4; X2 is selected from a group consisting of C and N; X3 is selected from a group consisting of N and O; X4 is selected from a group consisting of N and O; X5 is selected from a group consisting of a bond, CR4R4', NR4, O, S, SO, SO2; X6 represents N; X7 is selected from a group consisting of C and N; Q represents triazolyl.
EFFECT: invention also relates to a pharmaceutical composition containing a therapeutically effective amount of the disclosed compound as an active ingredient, use of the compound in making a medicinal agent for treating disorders mediated by mGluR5 and to a method of inhibiting activation of mGluR5 receptors.
25 cl, 82 ex
Title | Year | Author | Number |
---|---|---|---|
AZAINDOL DERIVATIVES AS FACTOR Xa INHIBITORS | 2004 |
|
RU2330853C2 |
PIPERIDINE DERIVATIVES | 2011 |
|
RU2554353C2 |
2-(PHENYL OR PYRID-3-YL)AMINOPYRIMIDINE DERIVATIVES AS MODULATORS OF LEUCINE-RICH REPEATING KINASE 2 (LRRK2) FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2647849C2 |
HETEROCYCLIC ARYL SULPHONES, SUITABLE FOR TREATING DISORDERS RESPONSIVE TO 5HT RECEPTOR MODULATION | 2007 |
|
RU2451012C2 |
OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | 2014 |
|
RU2674983C1 |
HETEROCYCLIC HIF ACTIVITY MODULATORS FOR TREATING DISEASES | 2013 |
|
RU2698197C2 |
ALLOSTERIC MODULATORS OF METABOLIC GLUTAMATE RECEPTORS | 2004 |
|
RU2360902C2 |
SUBSTITUTED MORPHOLINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF COUNTERACTION TO SUBSTANCE P OR INHIBITION OF NEUROKININ-1 RECEPTORS | 1995 |
|
RU2170233C2 |
TRIAZOLPYRIMIDINE COMPOUNDS AND THEIR USE IN TREATMENT OF CANCER | 2019 |
|
RU2793249C2 |
SUBSTITUTED AZOL DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THESE DERIVATIVES, AND METHODS OF TREATING PARKINSON'S DISEASE WITH USING THESE DERIVATIVES | 2010 |
|
RU2578596C2 |
Authors
Dates
2010-02-10—Published
2005-02-17—Filed